Disulfide-Bridged Cationic Dinuclear Ir(III) Complex with Aggregation-Induced Emission and Glutathione-Consumption Properties for Elevating Photodynamic Therapy
2024

New Iridium Complex for Cancer Treatment

publication 10 minutes Evidence: high

Author Information

Author(s): Huang Meijia, Cui Jie, Wu Qi, Liu Shengnan, Zhu Dongxia, Li Guangzhe, Bryce Martin R., Wang Dong, Tang Ben Zhong

Primary Institution: Northeast Normal University

Hypothesis

Can a dinuclear iridium complex with aggregation-induced emission and glutathione-consuming properties improve photodynamic therapy?

Conclusion

The dinuclear iridium complex Ir–S–S–Ir shows enhanced ROS production and effectively consumes glutathione, improving its efficacy in photodynamic therapy.

Supporting Evidence

  • Ir–S–S–Ir produced 33 times more singlet oxygen than a traditional iridium complex.
  • Ir–S–S–Ir effectively consumed glutathione in tumor cells.
  • Ir–S–S–Ir showed superior phototoxicity compared to Ir–C–C–Ir.
  • Cell experiments confirmed the enhanced ROS production capacity of Ir–S–S–Ir.

Takeaway

Scientists created a special iridium compound that helps kill cancer cells by making them produce more harmful oxygen when exposed to light and by using up a protective substance in the cells.

Methodology

The study involved synthesizing two dinuclear iridium complexes, testing their ability to produce reactive oxygen species, and evaluating their effects on glutathione levels in cancer cells.

Digital Object Identifier (DOI)

10.1021/acs.inorgchem.4c04571

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication